Logo image of ELMD

ELECTROMED INC (ELMD) Stock Fundamental Analysis

NYSEARCA:ELMD - US2854091087 - Common Stock

24.73 USD
+0.2 (+0.82%)
Last: 8/29/2025, 8:18:22 PM
25.1 USD
+0.37 (+1.5%)
After Hours: 8/29/2025, 8:18:22 PM
Fundamental Rating

6

Taking everything into account, ELMD scores 6 out of 10 in our fundamental rating. ELMD was compared to 190 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ELMD a very profitable company, without any liquidiy or solvency issues. ELMD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

ELMD had positive earnings in the past year.
ELMD had a positive operating cash flow in the past year.
ELMD had positive earnings in 4 of the past 5 years.
In multiple years ELMD reported negative operating cash flow during the last 5 years.
ELMD Yearly Net Income VS EBIT VS OCF VS FCFELMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

ELMD's Return On Assets of 13.65% is amongst the best of the industry. ELMD outperforms 95.26% of its industry peers.
The Return On Equity of ELMD (16.30%) is better than 91.58% of its industry peers.
ELMD has a Return On Invested Capital of 15.35%. This is amongst the best in the industry. ELMD outperforms 95.79% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ELMD is in line with the industry average of 8.46%.
The 3 year average ROIC (8.56%) for ELMD is below the current ROIC(15.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.65%
ROE 16.3%
ROIC 15.35%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ELMD Yearly ROA, ROE, ROICELMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ELMD has a better Profit Margin (11.66%) than 87.37% of its industry peers.
In the last couple of years the Profit Margin of ELMD has grown nicely.
With an excellent Operating Margin value of 14.58%, ELMD belongs to the best of the industry, outperforming 84.74% of the companies in the same industry.
ELMD's Operating Margin has improved in the last couple of years.
ELMD has a Gross Margin of 77.55%. This is amongst the best in the industry. ELMD outperforms 91.05% of its industry peers.
ELMD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.58%
PM (TTM) 11.66%
GM 77.55%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
ELMD Yearly Profit, Operating, Gross MarginsELMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

ELMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ELMD Yearly Shares OutstandingELMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ELMD Yearly Total Debt VS Total AssetsELMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ELMD has an Altman-Z score of 17.71. This indicates that ELMD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 17.71, ELMD belongs to the best of the industry, outperforming 95.26% of the companies in the same industry.
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.71
ROIC/WACC1.73
WACC8.87%
ELMD Yearly LT Debt VS Equity VS FCFELMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ELMD has a Current Ratio of 5.19. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.19, ELMD is in the better half of the industry, outperforming 77.37% of the companies in the same industry.
ELMD has a Quick Ratio of 4.84. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
ELMD has a better Quick ratio (4.84) than 80.53% of its industry peers.
Industry RankSector Rank
Current Ratio 5.19
Quick Ratio 4.84
ELMD Yearly Current Assets VS Current LiabilitesELMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.83% over the past year.
ELMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.82% yearly.
EPS 1Y (TTM)44.83%
EPS 3YN/A
EPS 5Y17.82%
EPS Q2Q%25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.27%

3.2 Future

The Earnings Per Share is expected to grow by 15.33% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.65% on average over the next years. This is quite good.
EPS Next Y17.51%
EPS Next 2Y15.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.48%
Revenue Next 2Y9.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
ELMD Yearly Revenue VS EstimatesELMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ELMD Yearly EPS VS EstimatesELMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.44, which means the current valuation is very expensive for ELMD.
74.74% of the companies in the same industry are more expensive than ELMD, based on the Price/Earnings ratio.
ELMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 25.05, ELMD can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ELMD is valued a bit cheaper than 74.21% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.76, ELMD is valued at the same level.
Industry RankSector Rank
PE 29.44
Fwd PE 25.05
ELMD Price Earnings VS Forward Price EarningsELMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

76.32% of the companies in the same industry are more expensive than ELMD, based on the Enterprise Value to EBITDA ratio.
89.47% of the companies in the same industry are more expensive than ELMD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.46
EV/EBITDA 19.24
ELMD Per share dataELMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

ELMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ELMD may justify a higher PE ratio.
A more expensive valuation may be justified as ELMD's earnings are expected to grow with 15.33% in the coming years.
PEG (NY)1.68
PEG (5Y)1.65
EPS Next 2Y15.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ELMD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTROMED INC

NYSEARCA:ELMD (8/29/2025, 8:18:22 PM)

After market: 25.1 +0.37 (+1.5%)

24.73

+0.2 (+0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-26 2025-08-26/amc
Earnings (Next)11-10 2025-11-10
Inst Owners50.06%
Inst Owner Change5.14%
Ins Owners7.54%
Ins Owner Change0%
Market Cap206.50M
Analysts82
Price Target33.66 (36.11%)
Short Float %4.3%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)2.94%
Max EPS beat(2)19.83%
EPS beat(4)4
Avg EPS beat(4)121.43%
Min EPS beat(4)2.94%
Max EPS beat(4)422.88%
EPS beat(8)6
Avg EPS beat(8)63.79%
EPS beat(12)8
Avg EPS beat(12)51.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.89%
Min Revenue beat(2)-2.37%
Max Revenue beat(2)4.16%
Revenue beat(4)2
Avg Revenue beat(4)1.31%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.61%
Revenue beat(12)6
Avg Revenue beat(12)0.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.88%
PT rev (3m)-10.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0.77%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 29.44
Fwd PE 25.05
P/S 3.36
P/FCF 17.46
P/OCF 17.18
P/B 4.7
P/tB 4.76
EV/EBITDA 19.24
EPS(TTM)0.84
EY3.4%
EPS(NY)0.99
Fwd EY3.99%
FCF(TTM)1.42
FCFY5.73%
OCF(TTM)1.44
OCFY5.82%
SpS7.36
BVpS5.26
TBVpS5.19
PEG (NY)1.68
PEG (5Y)1.65
Profitability
Industry RankSector Rank
ROA 13.65%
ROE 16.3%
ROCE 20.38%
ROIC 15.35%
ROICexc 23.51%
ROICexgc 24%
OM 14.58%
PM (TTM) 11.66%
GM 77.55%
FCFM 19.25%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ROICexc(3y)11.98%
ROICexc(5y)12.69%
ROICexgc(3y)12.25%
ROICexgc(5y)13.03%
ROCE(3y)11.36%
ROCE(5y)11.53%
ROICexcg growth 3Y14.49%
ROICexcg growth 5Y7.7%
ROICexc growth 3Y14.84%
ROICexc growth 5Y7.9%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
F-Score8
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 19.8%
Cap/Sales 0.32%
Interest Coverage 250
Cash Conversion 120.96%
Profit Quality 165.17%
Current Ratio 5.19
Quick Ratio 4.84
Altman-Z 17.71
F-Score8
WACC8.87%
ROIC/WACC1.73
Cap/Depr(3y)189.91%
Cap/Depr(5y)155.01%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.83%
EPS 3YN/A
EPS 5Y17.82%
EPS Q2Q%25%
EPS Next Y17.51%
EPS Next 2Y15.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.27%
Revenue Next Year10.48%
Revenue Next 2Y9.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.01%
EBIT growth 3Y27.97%
EBIT growth 5Y18.35%
EBIT Next Year137.93%
EBIT Next 3Y45.86%
EBIT Next 5YN/A
FCF growth 1Y648.35%
FCF growth 3Y48.86%
FCF growth 5Y48.48%
OCF growth 1Y2942.32%
OCF growth 3Y43.37%
OCF growth 5Y28.48%